Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01788410 · ClinicalTrials.gov registry record

MRI-Guided Cryoablation to Alleviate Pain in Head, Neck and Spine

A clinical trial of Neuropathy and Neuralgia, sponsored by Brigham and Women's Hospital.

Recruiting
Registry status
50
Enrollment target
1
Study location

NCT01788410 is a study of Neuropathy and Neuralgia that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 50 participants, below the 184-participant average among 22 other Neuropathy trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01788410, a study of Neuropathy and Neuralgia, is actively recruiting participants, sponsored by Brigham and Women's Hospital.

RECRUITING
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to provide pain relief to patients with facet joint disease or head and neck pain related to compression of a nerve root. The goal is to provide palliative care with superior efficacy and longer relief compared to current methods.

Interventions

  • PROCEDURE Cryoablation under image guidance
  • DEVICE MRI Seednet Cryotherapy System (Galil Medical)

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2013-05
Est. Completion 2030-05

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT01788410

The ClinicalTrials.gov registry entry for NCT01788410 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 184-participant average among 22 other Neuropathy trials with a reported enrollment target (73% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Neuropathy appearing as the primary indexed condition, and to 2 interventions - of which Cryoablation under image guidance is the first listed.

NCT01788410 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01788410 about?

NCT01788410 is a clinical study titled "MRI-Guided Cryoablation to Alleviate Pain in Head, Neck and Spine". The objective of this study is to provide pain relief to patients with facet joint disease or head and neck pain related to compression of a nerve root. The goal is to provide palliative care with superior efficacy and longer relief compared to current methods.

What is the current status of trial NCT01788410?

This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2013-05. Estimated completion is 2030-05.

What conditions does trial NCT01788410 study?

This clinical trial studies the following conditions: Neuropathy, Neuralgia, Facet Joints; Degeneration.

What interventions are being tested in trial NCT01788410?

The interventions under investigation include: Cryoablation under image guidance (PROCEDURE), MRI Seednet Cryotherapy System (Galil Medical) (DEVICE).

Who is sponsoring clinical trial NCT01788410?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01788410 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Neuropathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.